Patients gain access to clinical notes, lung cancer screening guidelines fall short, and AML standard remains elusive

Blood & Cancer

English - October 27, 2020 08:00 - 7 minutes - 10.2 MB - ★★★★★ - 31 ratings
Medicine Health & Fitness Science Life Sciences oncologists radiotherapy cancer chemotherapy doctors healthcare hematologists hematology immunotherapy marrow Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Hematology case review: Suspected ITP, presumed heparin-induced thrombocytopenia, and an ‘interesting’ case of anemia

Next Episode: How to use antiemetics: Dr. Paul Hesketh reviews ASCO’s guidelines on antiemetic use in cancer patients receiving checkpoint inhibitors or antineoplastic agents

Hematology-Oncology News:

National lung cancer screening guidelines may miss younger African American individuals at high risk: https://bit.ly/3e2CmhV

Standard treatment lacking in relapsed / refractory AML: https://bit.ly/3kzoUVh (03:08)

Patients can read your clinical notes starting Nov. 2: https://bit.ly/3mnuudL (05:40)

You can email the show at [email protected].